Daniel O'Day
Chairman & CEO, Gilead Sciences | Delivering Transformative Therapies through Innovation | Board Member, Georgetown University & PhRMA
San Francisco Bay Area
About
Working with Gilead employees around the world to create new possibilities in medicine. Delivering on our long term commitment to groundbreaking science and access so we can help make the world a better, healthier place.
Experience
-
Board Member at Georgetown University
Jul 2023 - Present · 3 yrs
-
Chairman and Chief Executive Officer at Gilead Sciences
Mar 2019 - Present · 7 yrs 4 mos
-
Board Member at PhRMA
Mar 2019 - Present · 7 yrs 4 mos
-
Board Member at Galapagos
Oct 2019 - 2024 · 4 yrs 4 mos
-
Roche (32 yrs 1 mo)
-
Chief Executive Officer, Roche Pharmaceuticals
2016 - 2019 · 3 yrs
-
Chief Operating Officer, Pharma Division
2012 - 2016 · 4 yrs
-
Chief Operating Officer, Diagnostics Division
2010 - 2012 · 2 yrs